N-acetyl-(±)-coniine

• 分子结构分类: 有机化合物 - 生物碱及其衍生物
• 英文名称: N-acetyl-(±)-coniine
• 英文别名: (+/-)-N-acetylconiine；1-acetyl-2-propyl-piperidine；1-Acetyl-2-propyl-piperidin；1-(2-Propylpiperidin-1-yl)ethanone
• 化学式: C₁₀H₁₉NO
• 分子量: 169.267
• InChiKey: YERZJAHNXJVEHZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  1-(allyloxy)-2-propylpiperidine 在 锌 作用下， 以 吡啶 为溶剂， 反应 20.0h， 生成 N-acetyl-(±)-coniine
  参考文献：
  名称：

  Studies on Difficult Intramolecular Hydroaminations in the Context of Four Syntheses of Alkaloid Natural Products

  摘要：

  Examples of intramolecular alkene hydroaminations forming six-membered ring systems are rare, especially for systems in which the double bond is disubstituted. Such cyclizations have important synthetic relevance. Herein we report a systematic study of these cyclizations using recently developed Cope-type hydroamination methodologies. Difficult intramolecular alkene hydroaminations were used as key steps in syntheses of 2-epi-pumiliotoxin C, coniine, N-norreticuline and desbromoarborescidine A. This effort required the development of optimized hydroamination conditions to improve the efficiency of the cyclizations. Collectively, our results show that Cope-type cyclizations can be achieved on a variety of challenging substrates and proceed under similar conditions for both N-H and N-substituted hydroxylamines.

  DOI：

  10.1021/jo4023149

文献信息

• Methods and compositions of treating a flaviviridae family viral infection
  申请人：Einav Shirit

  公开号：US20100015093A1

  公开（公告）日：2010-01-21

  Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.

  简要概述，本公开的实施例包括化合物、药物组合物、治疗感染黄病毒科病毒的宿主的方法、抑制宿主中HCV复制的方法、抑制NS4B多肽与HCV负链RNA的3′UTR结合的方法、治疗宿主肝纤维化的方法等。
• METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION
  申请人：Glenn Jeffrey S.

  公开号：US20120148534A1

  公开（公告）日：2012-06-14

  Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.

  简单地说，本公开的实施例包括化合物、药物组合物、治疗感染黄病毒科病毒的宿主的方法、抑制宿主中HCV复制的方法、抑制NS4B多肽与HCV负链RNA的3'UTR结合的方法、治疗宿主肝纤维化的方法等。
• Bourgeois, Joffre; Dion, Isabelle; Cebrowski, Pamela H., Journal of the American Chemical Society, 2009, vol. 131, p. 874 - 875
  作者：Bourgeois, Joffre、Dion, Isabelle、Cebrowski, Pamela H.、Loiseau, Francis、Bedard, Anne-Catherine、Beauchemin, Andre M.

  DOI：——

  日期：——
• Ladenburg, Chemische Berichte, 1893, vol. 26, p. 860
  作者：Ladenburg

  DOI：——

  日期：——
• US8940730B2
  申请人：——

  公开号：US8940730B2

  公开（公告）日：2015-01-27